The Department of Ophthalmology and Visual Sciences (DOVS) at The Chinese University of Hong Kong actively participated in the 2025 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO Annual Meeting 2025), held in Salt Lake City, Utah, from 4-8 May 2025.

A delegation of 19 representatives from DOVS, including five professors, four research staff, one visiting scholar, eight postgraduate students, and one undergraduate student, attended the meeting. They presented their latest research findings, took part in scientific discussions, and engaged in collaborative research meetings.

During the conference, Prof Calvin CP Pang, S.H. Ho Professor of Visual Sciences; Prof Jason CS Yam, Professor; Dr Carol YL Cheung, Dr Kelvin KL Chong, and Dr Chu Wai Kit, Associate Professors, along with other research staff and students, were invited to deliver presentations or undertake key roles at the event. In addition, Dr Emma A Ran, Scientific Officer, Dr Zhang Yuzhou, Postdoctoral Fellow, and Ms Li Yi, Postgraduate Student, were awarded ARVO Travel Grants in recognition of their outstanding research contributions.

To further strengthen international collaboration, the Department hosted a CUHK Reception Dinner on 6 May 2025, bringing together over 30 distinguished guests from 15 countries. The dinner, hosted by Prof Pang, Prof Yam, Dr Cheung, Dr Chong and Dr Chu, provided a valuable opportunity to reconnect with global partners and forge new academic ties.

The ARVO Annual Meeting 2025 is the premier global forum for eye and vision scientists to share the latest research findings and collaborate on innovative solutions. The ARVO Annual Meeting 2025 focused on how new information and technologies, including artificial intelligence, big data, CRISPR, mRNA technologies, sophisticated imaging modalities, virtual reality, and breakthroughs in gene therapy, are continually transforming vision research.

Here are some highlights of the Department’s contributions at the ARVO Annual Meeting 2025:

Members from the Department of Ophthalmology and Visual Sciences, CUHK	Major tasks in the ARVO Annual Meeting 2025
Prof Calvin CP PANG S.H. Ho Professor of Visual Sciences	Delivered Poster Presentation, “The Role of Trio- Based Exome Sequencing in Patients with Thyroid Eye Disease”.
Prof Jason CS YAM Professor	Delivered a Paper Presentation, “Seven-Year Clinical Trial of Low-concentration Atropine for Myopia Progression (LAMP1) Study: Phase 5 Report”.
Dr Carol YL CHEUNG Associate Professor	Delivered an Oral Presentation, “AI-based Retinal Image Analysis for Assessing Brain Health in Real-World”. Delivered a Paper Presentation: “Development of Vendor-Agnostic Multiple Retinal Disease Detection AI Model from 3D Optical Coherence Tomography Scans”.
Dr Kelvin KL CHONG Associate Professor	Delivered a Poster Presentation, “The Safety on the Anterior Chamber and Lens of Vectored Thermal Pulsation and Intense Pulsed Light Treatment for Meibomian Gland Dysfunction ”.
Dr CHU Wai Kit Associate Professor	Committee Chair for the Association for Research in Vision and Ophthalmology. Mentor of the ARVO Developing Country Eye Research Fellowship (DCERF) Program. Reviewer of the ARVO Resume Review Session. Delivered a Poster Presentation: “Use of Chinese Medicine as an Alternative Eye Disease Treatment in Hong Kong”.
Dr Emma A RAN Scientific Officer	Received ARVO Travel Grant Awards 2025. Delivered a Paper Presentation: “Building an Artificial Intelligence-Based Infrastructure for Prospectively Validating Glaucoma Detection from 3D Optical Coherence Tomography Scans in real-world”. Moderator for a Poster Presentation: “Generative AI and Deep Learning in the Real World”. Participated in the ARVO Women’s Leadership Development Program (WLDP) as a female scientist.
Dr LING Xiangtian Postdoctoral Fellow	Delivered a Poster Presentation: “Role of Family Factor in Shaping Children’s Ocular Microbiome”.
Dr ZHANG Yuzhou Postdoctoral Fellow	Received ARVO Travel Grant Awards 2025. Delivered a Paper Presentation: “Cost-Effectiveness Analysis of Low-concentration Atropine for Myopia Progression (LAMP1) Study”.
Ms Annie A LING Technician	Delivered a Poster Presentation: “Development of an Artificial Intelligence (AI) Model for Predicting Intraocular Pressure (IOP) Reduction After Phacoemulsification in Primary Angle Closure Glaucoma (PACG)”.
Dr FU Changzhen Visiting Scholar	Delivered a Poster Presentation: “Retinal Microglia Remain Activated After a Long Recovery from Acute Retinal Ischemia/Reperfusion Injury”.
Ms CHEN Shuying Postgraduate Student	Delivered a Poster Presentation: “Association of Polymorphisms in the Htra1 Gene with Primary Open-Angle Glaucoma”.
Mr HU Zhichao Postgraduate Student	Delivered a Poster Presentation: “Preliminary Analysis of the Short-term Efficacy of Traditional Chinese Medicine Ultrasonic Atomization Treatment for Dry Eye disease: a Randomized Control Trial”.
Ms LI Jiahui Postgraduate Student	Delivered a Poster Presentation: “Mechanistic Investigations of the Pro-Apoptotic Effects of Growth Hormone-Releasing Hormone Receptor Antagonists Mia-602 on Retinoblastoma”.
Ms LI Yi Postgraduate Student	Received ARVO Travel Grant Awards 2025. Delivered an Oral Presentation: “Effect of 0.01%, 0.025%, and 0.05% Atropine Eye Drops on Peripapillary Gamma Zone Changes”.
Ms LI Yingan Postgraduate Student	Delivered a Poster Presentation: “Associations of Long-term Joint Exposure to Multiple Ambient Air Pollutants with the Incidence of Age-related Eye Diseases”.
Ms PENG Yu Postgraduate Student	Delivered a Poster Presentation: “Ocular Surface Microbiota Profiles in Myopes and Nonmyopes”.
Ms YU Jun Postgraduate Student	Delivered a Poster Presentation: “Integrated Roles of Systemic Diseases and Serum Biomarkers in the Incidence of Age-related Macular Degeneration: the UK Biobank Study”.
Ms ZHANG Shuyi Postgraduate Student	Delivered a Paper Presentation: “Cost-Effectiveness of an AI-based 3D OCT Image Analysis for Diabetic Macular Edema Identification to Support Triage Screening”.
Ms Emily HY CHAN CUHK GPS Medical Student	Delivered a Poster Presentation: “The Growth Hormone-Releasing Hormone Receptor Antagonist Mia-602 Potentiates Chemotherapy Effects on Retinoblastoma”.

(Professors, research staff and students of the same rank are listed in alphabetical order of their surnames)